• Product NameFlubendazole
  • CasNo. 31430-15-6
  • MFC16H12FN3O3
  • MW313.288
  • Purity
  • Appearancealmost white powder
  • Packing
  • Contact usInquiry

Product Details

CasNo: 31430-15-6

MF: C16H12FN3O3

Appearance: almost white powder

Factory supply Flubendazole 31430-15-6 with sufficient production capacity

  • Molecular Formula:C16H12FN3O3
  • Molecular Weight:313.288
  • Appearance/Colour:almost white powder 
  • Melting Point:290 °C 
  • Refractive Index:1.685 
  • PKA:10.66±0.10(Predicted) 
  • PSA:84.08000 
  • Density:1.444 g/cm3 
  • LogP:3.18430 

Flubendazole(Cas 31430-15-6) Usage

Therapeutic Function

Anthelmintic

Biochem/physiol Actions

Flubendazole, an antithelmintic, has been widely used in treating intestinal parasites. Additionally, Flubendazole has been reported to exert anticancer activities.

Definition

ChEBI: A member of the class of mebendazole in which the benzoyl group is replaced by a p-fluorobenzoyl group. A broad-spectrum anthelmintic, it is used, particularly in veterinary medicine, for the treatment of nematodal infections.

General Description

Flubendazole is a benzimidazole anthelmintic drug that is available from a number of sources. The benzimidazoles are a group of compounds that include albendazole, flubendazole, mebendazole, niridazole, triabendazole, and triclabendazole.
Uses Flubendazole, belonging to benzimidazole, is a broad-spectrum insect repellent and has been repurposed as a promising anticancer drug. In recent years, many studies have shown that flubendazole plays an anti-tumor role in different types of cancers, including breast cancer, melanoma, prostate cancer, colorectal cancer, and lung cancer.

Who Evaluation

Evaluation year: 1993

InChI:InChI=1/C16H12FN3O3/c1-23-16(22)20-15-18-12-7-4-10(8-13(12)19-15)14(21)9-2-5-11(17)6-3-9/h2-8H,1H3,(H2,18,19,20,22)

31430-15-6 Relevant articles

Flubendazole exhibits anti-glioblastoma effect by inhibiting STAT3 and promoting cell cycle arrest

Barbora Vítovcová, Veronika Skarková, Radim Havelek, Jiří Soukup, Ananya Pande, Kateřina Caltová & Emil Rudolf

Scientific Reports volume 13, Article number: 5993 (2023)

In our study, we demonstrated that repurposed drug flubendazole (FLU) significantly inhibits proliferation and survival of GBM cells. FLU exerted its effect by affecting microtubule structure and our results also suggest that FLU influences tubulins expression to a certain degree.

Flubendazole Plays an Important Anti-Tumor Role in Different Types of Cancers

Chaoran Chen,1,† Yueming Ding,1,† Huiyang Liu,2 Mengyao Sun,3 Honggang Wang,2,* and Dongdong Wu2,4,*

, Int J Mol Sci. 2022 Jan; 23(1): 519.

FLU suppresses breast cancer through the inhibition of proliferation, metastasis and drug resistance mainly by targeting breast CS-like cells via inhibiting cell cycle progression and tubulin polymerization. FLU suppresses TNBC mainly through the inhibition of breast CS-like cells via inhibiting STAT3 activation; FLU mitigates resistance to trastuzumab through the inhibition of CS-like cell properties and the HER2 pathway, and the induction of apoptosis and G2/M phase arrest in HER2-positive breast cancer

31430-15-6 Upstream products

  • 66938-86-1
    66938-86-1

    (3,4-diaminophenyl)(4-fluorophenyl)ketone

  • 40943-37-1
    40943-37-1

    O-methyl-N-(methoxycarbonyl)-isourea

  • 96-99-1
    96-99-1

    4-chloro-3-nitrobenzoate

  • 38818-50-7
    38818-50-7

    4-chloro-3-nitro-benzoyl chloride

31430-15-6 Downstream products

  • 923672-31-5
    923672-31-5

    C17H15FN3O7P

  • 923672-32-6
    923672-32-6

    C17H15FN3O7P

Relevant Products